University Hospital of Ulm
Ulm, Germany
University hospital in Ulm, Baden-Württemberg
Albert-Einstein-Allee 23, 89081 Ulm
About University Hospital of Ulm
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
9
Celgene
7
Scandion Oncology A/S
2
Abbott Medical Devices
1
Affimed GmbH
1
Biotronik SE & Co. KG
1
ImmunoGen, Inc.
1
Orion Corporation, Orion Pharma
1
Ulrich Ronellenfitsch, MD
1
Clinical Trials at University Hospital of Ulm
During the past decade, University Hospital of Ulm conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
2009-01-27
2020-10-27
Completed
317
Clinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT)
2008-05-01
2015-09-01
Terminated
163
Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation
2011-03-01
2018-07-13
Completed
144
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
2010-07-01
Recruiting
Influence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral Oxygenation
2011-06-01
2012-07-01
Completed
24
Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
2011-04-01
2016-03-01
Completed
35
Cerebral Tissue Oxygenation in Very Low Birthweight Infants in the First 3 Days of Life
2011-04-01
2019-06-01
Unknown status
200
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University Hospital of Ulm" #1 sponsor was "University of Ulm" with 9 trials, followed by "Celgene" with 7 trials
sponsored, "Scandion Oncology A/S" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Affimed GmbH"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Ulm"
#1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Alcedis GmbH" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "Jazz Pharmaceuticals" with 1 trials as a collaborator and "National Center for Tumor Diseases, Heidelberg" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at University Hospital of Ulm
According to Clinical.Site data, the most researched conditions in "University Hospital of Ulm" are
"Acute Myeloid Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Aortic Valve Disease" (1 trials). Many other conditions were trialed in "University Hospital of Ulm" in a lesser frequency.
Clinical Trials Intervention Types at University Hospital of Ulm
Most popular intervention types in "University Hospital of Ulm" are "Drug" (17 trials), "Procedure" (2 trials), "Device" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (2 trials), "Cytarabine" (2 trials), "Gemcitabine" (2 trials), "Placebo" (2 trials) and "SCO-101" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University Hospital of Ulm
The vast majority of trials in "University Hospital of Ulm" are
24 trials for "All" genders.
Clinical Trials Status at University Hospital of Ulm
Currently, there are NaN active trials in "University Hospital of Ulm".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in University Hospital of Ulm,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital of Ulm, 7 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".